Susvimo, Genentech’s first surgical device in ophthalmology, offers continuous delivery for retinal diseases. It reduces treatment burden, improves outcomes, and pioneers innovation in eye care. The brand focuses on educating surgeons, proving clinical value, shaping payer ecosystems, and forging partnerships with key clinics for holistic patient solutions.

BBH London